These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 7531051

  • 1. Molecular mechanisms of immunosuppressive agents.
    Borel JF, Baumann G.
    Bull Mem Acad R Med Belg; 1994; 149(1-2):97-101; discussion 101-3. PubMed ID: 7531051
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE.
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
    Kay JE.
    Biochem J; 1996 Mar 01; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
    [No Abstract] [Full Text] [Related]

  • 5. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B, Weber E, Mihatsch MJ.
    Exp Nephrol; 1994 Mar 01; 2(6):324-33. PubMed ID: 7532090
    [Abstract] [Full Text] [Related]

  • 6. Lessons from molecular matchmakers.
    Teague S.
    Nat Struct Biol; 1995 May 01; 2(5):360-1. PubMed ID: 7545076
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biology of cyclosporin A and FK506.
    Bierer BE.
    Prog Clin Biol Res; 1994 May 01; 390():203-23. PubMed ID: 7536944
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
    Braun W, Kallen J, Mikol V, Walkinshaw MD, Wüthrich K.
    FASEB J; 1995 Jan 01; 9(1):63-72. PubMed ID: 7529736
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?
    Schreier MH, Baumann G, Zenke G.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):502-7. PubMed ID: 7679818
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunophilin structure: a template for immunosuppressive drug design?
    Walkinshaw MD, Kallen J, Weber HP, Widmer A, Widmer H, Zurini M.
    Transplant Proc; 1992 Aug 01; 24(4 Suppl 2):8-13. PubMed ID: 1496694
    [No Abstract] [Full Text] [Related]

  • 17. Immunosuppressor binding to the immunophilin FKBP59 affects the local structural dynamics of a surface beta-strand: time-resolved fluorescence study.
    Rouviere N, Vincent M, Craescu CT, Gallay J.
    Biochemistry; 1997 Jun 17; 36(24):7339-52. PubMed ID: 9200682
    [Abstract] [Full Text] [Related]

  • 18. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.
    Baughman G, Wiederrecht GJ, Campbell NF, Martin MM, Bourgeois S.
    Mol Cell Biol; 1995 Aug 17; 15(8):4395-402. PubMed ID: 7542743
    [Abstract] [Full Text] [Related]

  • 19. The human erythrocyte membrane contains a novel 12-kDa inositolphosphate-binding protein that is an immunophilin.
    Cunningham EB.
    Biochem Biophys Res Commun; 1995 Oct 04; 215(1):212-8. PubMed ID: 7575593
    [Abstract] [Full Text] [Related]

  • 20. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes.
    Clipstone NA, Fiorentino DF, Crabtree GR.
    J Biol Chem; 1994 Oct 21; 269(42):26431-7. PubMed ID: 7523407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.